Back to search
Ménière's Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ménière's Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ménière's Disease trials you may qualify forStudy of the safety of open-label SPI-1005 400 mg BID treatment in adults with Meniere's Disease (MD) for 6 or 12 months to support chronic or chronic intermitt…
Ménière's disease was first described by Prosper Ménière in 1861 as a balance disorder originating in the inner ear. It is diagnosed based on a characteristic c…
The purpose of this study is to investigate the efficacy of a mastoid treatment device in patients with active Ménière's disease that is not controlled by tradi…
Evaluation of the diagnostic and prognostic efficacy of nuclear magnetic resonance imaging in patients with acute sensorineural hearing loss or in patients suff…
The CAVA trial is a diagnostic accuracy multicentre device trial which aims to quantify the extent to which the CAVA system can differentiate three common inner…